Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Cash Flow
Glenmark Pharmaceuticals Ltd.
BSE Code 532296
ISIN Demat INE935A01035
Book Value (Rs) 650.55
NSE Code GLENMARK
Dividend Yield % 0.24
Market Cap(Rs Mn) 292488.02
TTM PE(x) 70.29
TTM EPS(Rs) 14.75
Face Value (Rs) 1  
Type:
(Rs. in Million)
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax8684.5114412.4613824.7510960.7613006.29
Adjustment14719.637871.086448.186362.283298.35
Changes In working Capital-10744.81-5612.61-3858.381270.641363.41
Cash Flow after changes in Working Capital12659.3316670.9316414.5518593.6817668.05
Cash Flow from Operating Activities6253.9211086.5211312.1313924.1313241.71
Cash Flow from Investing Activities-5284.91-3332.80-6752.36-7835.17-6989.93
Cash Flow from Financing Activities-774.56-5204.91-4417.79-4446.63-7387.35
Net Cash Inflow / Outflow194.452548.81141.981642.33-1135.57
Opening Cash & Cash Equivalents14105.2611380.9511102.759362.7812333.56
Cash & Cash Equivalent on Amalgamation / Take over / Merger6.680000
Cash & Cash Equivalent of Subsidiaries under liquidations00000
Translation adjustment on reserves / op cash balalces frgn subsidiaries00000
Effect of Foreign Exchange Fluctuations123.87175.50136.2297.64-1835.21
Closing Cash & Cash Equivalent14430.2614105.2611380.9511102.759362.78